1 / 3
google
Details
- Product number
- 6819901
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- ripretinibum 50 mg, hypromellosi acetas succinas, cellulosum microcristallinum, lactosum monohydricum 179 mg, crospovidonum, silica colloidalis anhydrica, magnesii stearas, pro compresso.
Articles (1)
Qinlock 50 mg, Tabletten
Tabletten
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ripretinibum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
179.0 MG | Substance | HBESI |
|
crospovidonum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 18514.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Deciphera Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 68199
- Drug name
- Qinlock, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EX19
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 07/10/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- QINLOCK cpr 50 mg fl 90 pce
- Description (DE)
- QINLOCK Tabl 50 mg Fl 90 Stk
- Market launch
- 07/10/2021
- Narcotic (BTM)
- No